When we stratified the soluble mediator data by disease status, as mentioned previously, unaffected FDRs of SLE patients not included in the current study had the highest plasma levels of IL-6 and IP-10, significantly higher than both cases and unrelated, unaffected controls, independent of medication usage. Here, CXCL10 is linked to systemic lupus erythematosus.